-
Loading metrics
Open Access
Peer-reviewed
Research Article
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
-
Isabelle Leduc ,
Contributed equally to this work with: Isabelle Leduc, Kristie L. Connolly
Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
Kristie L. Connolly ,
Contributed equally to this work with: Isabelle Leduc, Kristie L. Connolly
Roles Data curation, Investigation, Supervision, Writing – original draft
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
Afrin Begum,
Roles Investigation
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
Knashka Underwood,
Roles Investigation
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
Stephen Darnell,
Roles Investigation
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
William M. Shafer,
Roles Methodology, Writing – review & editing
Affiliations Department of Microbiology and Immunology and The Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, United States of America, Laboratories of Bacterial Pathogenesis, Atlanta Veterans Affairs Medical Center, Decatur, Georgia, United States of America
⨯ -
Jacqueline T. Balthazar,
Roles Investigation
Affiliation Department of Microbiology and Immunology and The Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia, United States of America
⨯ -
Andrew N. Macintyre,
Roles Investigation
Affiliation Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America
⨯ -
Gregory D. Sempowski,
Roles Methodology, Writing – review & editing
Affiliation Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina, United States of America
⨯ -
Joseph A. Duncan,
Roles Investigation, Writing – review & editing
Affiliations Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina, United States of America, Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America
⨯ -
Marguerite B. Little,
Roles Investigation
Affiliation Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina, United States of America
⨯ -
Nazia Rahman,
Roles Investigation
Affiliation Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America
⨯ -
Eric C. Garges,
Roles Investigation, Writing – review & editing
Affiliation Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, Maryland, United States of America
⨯ -
Ann E. Jerse
Roles Conceptualization, Formal analysis, Methodology, Supervision, Writing – original draft, Writing – review & editing
* E-mail: ann.jerse1@usuhs.edu
Affiliation Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, United States of America
⨯
The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
- Isabelle Leduc,
- Kristie L. Connolly,
- Afrin Begum,
- Knashka Underwood,
- Stephen Darnell,
- William M. Shafer,
- Jacqueline T. Balthazar,
- Andrew N. Macintyre,
- Gregory D. Sempowski,
- Joseph A. Duncan
-
- Published: December 8, 2020
- https://doi.org/10.1371/journal.ppat.1008602
- See the preprint